ModivCare Past Earnings Performance
Past criteria checks 0/6
ModivCare's earnings have been declining at an average annual rate of -67.1%, while the Healthcare industry saw earnings growing at 5.4% annually. Revenues have been growing at an average rate of 16.6% per year.
Key information
-67.1%
Earnings growth rate
-66.8%
EPS growth rate
Healthcare Industry Growth | 8.5% |
Revenue growth rate | 16.6% |
Return on equity | n/a |
Net Margin | -6.6% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Investors Still Aren't Entirely Convinced By ModivCare Inc.'s (NASDAQ:MODV) Revenues Despite 26% Price Jump
Aug 31Is ModivCare (NASDAQ:MODV) A Risky Investment?
Jul 11ModivCare Inc. (NASDAQ:MODV) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
Apr 04ModivCare Inc. (NASDAQ:MODV) Just Reported Earnings, And Analysts Cut Their Target Price
Feb 29ModivCare (NASDAQ:MODV) Seems To Be Using A Lot Of Debt
Feb 22Sentiment Still Eluding ModivCare Inc. (NASDAQ:MODV)
Jan 25Is ModivCare (NASDAQ:MODV) A Risky Investment?
Nov 08Here's Why ModivCare (NASDAQ:MODV) Is Weighed Down By Its Debt Load
Aug 03Is ModivCare (NASDAQ:MODV) A Risky Investment?
Apr 17Is There An Opportunity With ModivCare Inc.'s (NASDAQ:MODV) 49% Undervaluation?
Feb 24Does ModivCare (NASDAQ:MODV) Have A Healthy Balance Sheet?
Oct 12ModivCare: ROIC And Continuing Value Are Narrowing - Rating It A Hold
Sep 02Modivcare names finance boss Heath Sampson as interim CEO
Aug 02ModivCare (NASDAQ:MODV) Has A Somewhat Strained Balance Sheet
Jul 12Are Investors Undervaluing ModivCare Inc. (NASDAQ:MODV) By 37%?
May 10ModivCare (NASDAQ:MODV) Takes On Some Risk With Its Use Of Debt
Mar 04Revenue & Expenses Breakdown
How ModivCare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 2,788 | -183 | 300 | 0 |
30 Jun 24 | 2,773 | -161 | 299 | 0 |
31 Mar 24 | 2,773 | -223 | 302 | 0 |
31 Dec 23 | 2,751 | -204 | 305 | 0 |
30 Sep 23 | 2,702 | -206 | 319 | 0 |
30 Jun 23 | 2,663 | -230 | 325 | 0 |
31 Mar 23 | 2,592 | -36 | 325 | 0 |
31 Dec 22 | 2,504 | -32 | 322 | 0 |
30 Sep 22 | 2,426 | -56 | 324 | 0 |
30 Jun 22 | 2,272 | -35 | 317 | 0 |
31 Mar 22 | 2,118 | -25 | 294 | 0 |
31 Dec 21 | 1,997 | -7 | 272 | 0 |
30 Sep 21 | 1,820 | 23 | 234 | 0 |
30 Jun 21 | 1,647 | 66 | 200 | 0 |
31 Mar 21 | 1,455 | 37 | 175 | 0 |
31 Dec 20 | 1,369 | 32 | 142 | 0 |
30 Sep 20 | 1,355 | 23 | 101 | 0 |
30 Jun 20 | 1,428 | -5 | 82 | 0 |
31 Mar 20 | 1,509 | 5 | 66 | 0 |
31 Dec 19 | 1,510 | -9 | 63 | 0 |
30 Sep 19 | 1,486 | -2 | 63 | 0 |
30 Jun 19 | 1,436 | 0 | 64 | 0 |
31 Mar 19 | 1,416 | 7 | 67 | 0 |
31 Dec 18 | 1,385 | 12 | 75 | 0 |
30 Sep 18 | 1,125 | 42 | 41 | 0 |
30 Jun 18 | 1,191 | 45 | 43 | 0 |
31 Mar 18 | 1,255 | 45 | 42 | 0 |
31 Dec 17 | 1,318 | 40 | 70 | 0 |
30 Sep 17 | 1,603 | -23 | 70 | 0 |
30 Jun 17 | 1,606 | -32 | 68 | 0 |
31 Mar 17 | 1,596 | -34 | 67 | 0 |
31 Dec 16 | 1,234 | 12 | 38 | 0 |
30 Sep 16 | 1,566 | -35 | 63 | 0 |
30 Jun 16 | 1,533 | -43 | 66 | 0 |
31 Mar 16 | 1,440 | -44 | 66 | 0 |
31 Dec 15 | 1,478 | -40 | 73 | 0 |
30 Sep 15 | 1,473 | 10 | 72 | 0 |
30 Jun 15 | 1,403 | 17 | 69 | 0 |
31 Mar 15 | 1,267 | 22 | 54 | 0 |
31 Dec 14 | 1,093 | 25 | 60 | 0 |
30 Sep 14 | 1,045 | 16 | 44 | 0 |
30 Jun 14 | 1,012 | 18 | 38 | 0 |
31 Mar 14 | 1,131 | 19 | 49 | 0 |
31 Dec 13 | 799 | 13 | 26 | 0 |
Quality Earnings: MODV is currently unprofitable.
Growing Profit Margin: MODV is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MODV is unprofitable, and losses have increased over the past 5 years at a rate of 67.1% per year.
Accelerating Growth: Unable to compare MODV's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MODV is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.3%).
Return on Equity
High ROE: MODV's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.